Navigation Links
US Preparing To Answer Japan's Queries On Beef Exports

WASHINGTON - U.S. Agriculture Secretary Mike Johanns said that the department officials are working on answers to the questions posed by Japan over the exports of banned cattle // parts to that country. Johanns said that the information would soon be intimated to the Japanese officials.

"We have received the questions from Japan about the report that we submitted a few weeks ago," Johanns told reporters. “I did not see anything in those questions that was terribly surprising. We should have that information back to Japan maybe even as early as next week. The process continues to go along very well." Japan banned beef imports from US after inspectors discovered spinal column in veal shipments. This ban resulted over fears of t mad cow disease, or bovine spongiform encephalopathy (BSE). This particular action came within 30 days of Japan lifting the curbs on US beef imports. Japan has asked for some safeguards including the sifting of risky parts like spinal column. "My hope is that there's a point where we can get the technical people together to resolve the final issues that are there - Japan had talked about some additional requirements related to inspection -- and get those identified and then move to reopen the market to Japanese beef," Johanns said. "So far, so good." The U.S. Agriculture Department has taken serious note of the issue and has compiled a report on how to prevent such incidents in future.
'"/>




Page: 1

Related medicine news :

1. Preparing For The Worst Does Not Serve Any Purpose
2. Answer on SARS 3 to 4 weeks away
3. Answers For OCD soon
4. The Answer To Prevent Osteoporosis
5. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
6. An Answer To Obesity: Weight Control Protein
7. Chronic Myelogenous Leukemia (CML) Has An Answer Now!
8. Synthetic Bone Tissue Could Be the Answer to Disfigurement Caused by Oral Cancer
9. Emotional Engagement of Husband - A Final Answer To What Women Want
10. Running Alone Might Not Be The Answer
11. Cancer Vaccine Could Serve As an Answer to Prevent Most of the Cancer
Post Your Comments:
(Date:9/4/2008)...Medicare Advantage (MA) plans will be paid an aver...d to what the same enrollee would have cost in the...ording to a new report from The Commonwealth Fund....ted by the Medicare Improvements for Patients and ...ffect beginning in 2010 had been fully in place i...
(Date:9/4/2008)...ncreatic tumors , , THURSDAY, Sept. 4 (H...veries involving genetic mutations of two deadly c...atic cancer -- may lead to new treatments and even...esent the most complete genetic analysis to date o...p of these deadly cancers," Kenneth Kinzler, a pro...
(Date:9/4/2008)...ewswire/ -- Martin Schiff, M.D.,is an illustrious ...ight,control and weight loss. His career is detail... West," "Who,s Who in America," "Who,s Who in,the ...d other honor rolls., Dr. Schiff recently retired...e, misleading theories and notions concerning weig...
(Date:9/4/2008)...mber,s Ovarian Cancer Awareness ...swire/ -- Today the National Ovarian Cancer,Coalit...ive, Eva,s Divas,with a celebrity red-carpet even...amily who will be the first to pledge to empower a... risk factors of ovarian cancer.,NOCC spokesperson...
Breaking Medicine News(10 mins):Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2Health News:Genetic Mutations Linked to Deadly Cancers 2Health News:Genetic Mutations Linked to Deadly Cancers 3Health News:Genetic Mutations Linked to Deadly Cancers 4Health News:Phone World-famed Martin Schiff, M.D., at 310-454-6172 for Free Weight Loss 'No Diet, No Stuff' Method. Hates Diets, Loves to Have People Help Themselves 2Health News:National Ovarian Cancer Coalition and CSI: Miami Star Eva La Rue Launch Eva's Divas in Hollywood to Educate Women Nationwide About Ovarian Cancer 2Health News:National Ovarian Cancer Coalition and CSI: Miami Star Eva La Rue Launch Eva's Divas in Hollywood to Educate Women Nationwide About Ovarian Cancer 3
...PMER (Jawaharlal Institute of Postgraduate Medical... a 2-day //long strike to protest against the gove...n higher educational institutes. A spokesman of t...d that they had submitted a memo to the government...
...d all the public sector giants to dissociate thems... Tobacco Day' today, he has pleaded the public sec...), General Insurance Corporation and Unit Trust of...bacco Company (ITC). "The biggest stake holder in ...
...red striking medicos to immediately call off their...// , and resume work within three days. The court ...cos - also warned that strong action will be taken...emented. "We direct that all strikes, protests an...
...t evidence to prove the link between pregnancy, mo...ated that women who delivered vaginally// are the ... pelvic organ prolapse in contrast to those underw...he women in this study group who gave birth vagina...
Other Medicine News:Health News:Pregnancy and Mode of Delivery May Be A Cause For Pelvic Floor Disorders 2
(Date:9/3/2008)...an College of Rheumatology Research and Education ...nificant Advances in Detecting, ... /- For the first time during its,unp...d arthritis, the,American College of Rheumatology ... information acquired from research funded by the ...
(Date:9/3/2008)..., Belgium and GENEVA, Sept. 3 /- Arte...one in CHO based monoclonal antibody,production wi... 31 grams,per liter. This record level was accompl...es: (1) a high-performance stable Selexis CHO,prod...ding scientists at,Selexis SA using their propriet...
(Date:9/3/2008)... Company to Discuss Phase 3 Plans with FDA, P...apeutics, Inc.,announced today that it successful...pment of the company,s new, innovative low-dose, o... refers to by its internal product,code AG-200-15....ly met its,primary endpoint of ovulation suppressi...
(Date:9/3/2008)...to be Evaluated in Repeat-Dosing Study in Subjects...FirstCall/ -- Sangamo,BioSciences, Inc. (Nasdaq: ...2 clinical trial (SB-509-801) to evaluate its drug...enerative motor-neuron disease for which there,are...s drug, SB-509, is an injectable formulation of a ...
Breaking Medicine Technology:New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Victims of child maltreatment more likely to perpetrate youth violence intimate partner violence 1961 1Victims of child maltreatment more likely to perpetrate youth violence intimate partner violence 1961 2Chinese takeaway in the Wadden Sea 1957 1InSightec Resumes Clinical Trials for Non Invasive Treatment of Brain Tumors 806 1InSightec Resumes Clinical Trials for Non Invasive Treatment of Brain Tumors 806 2InSightec Resumes Clinical Trials for Non Invasive Treatment of Brain Tumors 806 3Pharmacopeia Earns Milestone Payment From Schering Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate 379 1Pharmacopeia Earns Milestone Payment From Schering Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate 379 2Pharmacopeia Earns Milestone Payment From Schering Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate 379 3Pharmacopeia Earns Milestone Payment From Schering Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate 379 4
...cans with Family History of ESRD Are at High,Risk ... percent of U.S.,adults have a family history of e...ls appear to be at increased risk of developing,ki...ril Journal of,the American Society of Nephrology....quent in,African-Americans, who are also at substa...
...ESS WIRE)--Mar 12, 2007 - Ceragenix Pharmaceutical...focused on,infectious disease and dermatology, tod...nin compound demonstrated virtually no biofilm,for...ane catheters treated with Ceragenins,were soaked ...an,untreated catheter. At day 21, the catheters we...
Other Medicine Technology:Nearly 1 in 10 Americans Has A Relative With Kidney Failure 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 3
...A lower cost alternative to Equalizers, the patent...ransfers between two different vessel configuratio...an be quickly and easily adjusted for test tubes (...onomic Design for Unparalleled Comfort Pick one o...
...A lower cost alternative to Equalizers, the patent...ransfers between two different vessel configuratio...an be quickly and easily adjusted for test tubes (...onomic Design for Unparalleled Comfort Pick one o...
...A lower cost alternative to Equalizers, the patent...ransfers between two different vessel configuratio...an be quickly and easily adjusted for test tubes (...onomic Design for Unparalleled Comfort Pick one o...
...A lower cost alternative to Equalizers, the patent...ransfers between two different vessel configuratio...an be quickly and easily adjusted for test tubes (...onomic Design for Unparalleled Comfort Pick one o...
Medicine Products: